🇺🇸 Remifentanil Injection plus 30% in United States

Remifentanil Injection plus 30% (Remifentanil Injection plus 30%) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Remifentanil Injection plus 30% in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Remifentanil Injection plus 30% approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Remifentanil Injection plus 30% in United States?

University Hospital, Toulouse is the originator. The local marketing authorisation holder may differ — check the official source linked above.